MRI comparable to Ga-68 PSMA PET/CT for prostate cancer diagnosis
MRI performs comparably to Gallium-68 (Ga-68) PSMA PET/CT for prostate cancer diagnosis and treatment tracking, according to research delivered at the recent RSNA meeting."68Ga PSMA PET/CT and prostate MRI may be complementary in both initial diagnosis and therapy planning, including guiding radiation where it may be the appropriate therapeutic approach," presenter Sean Gharai, MD, of Georgetown University in Washington, DC, and colleagues noted. Gharai shared the research on November 26.Ga-68 PSMA PET/CT imaging has been used mainly to assess prostate cancer's response to initial treatment with surgery or radiation therap...
Source: AuntMinnie.com Headlines - December 20, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Subspecialties Genitourinary Radiology Source Type: news
MRI comparable to 68Ga PSMA PET/CT for prostate cancer diagnosis
MRI performs comparably to 68Ga PSMA PET/CT for prostate cancer diagnosis and treatment tracking, according to research delivered at the recent RSNA meeting."68Ga PSMA PET/CT and prostate MRI may be complementary in both initial diagnosis and therapy planning, including guiding radiation where it may be the appropriate therapeutic approach," presenter Sean Gharai, MD, of Georgetown University in Washington, DC, and colleagues noted. Gharai shared the research on November 26.68Ga PSMA PET/CT imaging has been used mainly to assess prostate cancer's response to initial treatment with surgery or radiation therapy, according to...
Source: AuntMinnie.com Headlines - December 20, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Subspecialties Genitourinary Radiology Source Type: news
Almost 40,000 men at high-risk of prostate cancer have now taken vital 30-second checks via Paddy Power's big-money sponsorship of the Ally Pally World Darts Championship
A total of 48,728 people have now completed Prostate Cancer UK's online checker since November 30, five times higher than during the same time period last year. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2023 Category: Consumer Health News Source Type: news
Lantheus and Point Biopharma shares drop on prostate cancer treatment data
Shares of Lantheus Holdings Inc. LNTH, and Point Biopharma Global Inc. PNT, fell sharply premarket on Monday after the companies released new data from a trial of their experimental treatment for prostate cancer. The therapy, Lu-PNT2002, met the trial’s primary goal, with a median progression-free…#lantheusholdingsinc #pnt #novartisags #nvs #lupnt2002 #pointbiopharma #novartisamerican (Source: Reuters: Health)
Source: Reuters: Health - December 18, 2023 Category: Consumer Health News Source Type: news
PSMA-PET shows promise in patients with IBD
This study demonstrates that PSMA-targeted F-18 DCFPyL PET can effectively detect regions of inflamed mucosa in patients with IBD, suggesting its utility as a noninvasive imaging agent to assess location, extent, and disease activity,” the group concluded.The full study is available here. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 18, 2023 Category: Radiology Authors: Will Morton Tags: Gastrointestinal Radiology Source Type: news
Patti Payne: Former United Way of King County CEO battles prostate cancer
He says his cancer prognosis ‘is much better than it once was.' (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 14, 2023 Category: Biotechnology Authors: Patti Payne Source Type: news
News at a glance: AI rules for Europe, vaccines for Africa, and a union for NIH early-career researchers
HEALTH EQUITY
A billion-dollar boost for vaccinemaking in Africa
Gavi, the Vaccine Alliance, has committed up to $1 billion to bolster Africa’s ability to sustainably produce its own doses of lifesaving vaccines. Manufacturers based in Africa produce only 1% of the vaccine doses used on the continent. Last week, Gavi announced that with money left over from the COVID-19 Vaccines Global Access Facility—an effort to provide an equitable distribution of COVID-19 vaccines—it would create the African Vaccine Manufacturing Accelerator (AVMA) to focus on preventing 11 priority infectious diseases. As ...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news
Network connectivity between psychological resilience and depression in prostate cancer patients - Sharpley CF, Arnold WM, Christie DRH, Bitsika V.
OBJECTIVES: Prostate cancer (PCa) patients often experience depression. One possible buffer against stress-related depression is psychological resilience (PR), which has been described as heterogeneous in structure, like major depressive disorder (MDD). Al... (Source: SafetyLit)
Source: SafetyLit - December 14, 2023 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
IBA to install cyclotron in Poland
Proton therapy developer Ion Beam Application (IBA) will install a Cyclone 30XP in Poland for the production of astatine-211 (At-211) for oncology applications. At-211 is an alpha particle emitter used in oncology for targeted therapies to treat brain, thyroid, ovarian, breast, and prostate cancer. This is the company’s third installation in Europe for A-211 production, following earlier installations in Germany and France. Beyond At-211, the company is also developing accelerator applications for other theranostic isotopes, IBA said. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 13, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Over 25,000 men have taken life-saving 30-second prostate cancer checks after Ally Pally darts sponsor Paddy Power pledged £1m to tackle the killer disease
New data shows the number of people completing Prostate Cancer UK's online checker was five times higher than during the same time period last year. (Source: the Mail online | Health)
Source: the Mail online | Health - December 12, 2023 Category: Consumer Health News Source Type: news
AI predicts responses in patients with prostate cancer
An AI model based on F-18 DCFPyL PSMA-PET/CT images shows promise for predicting treatment response in patients with metastatic castration-resistant prostate cancer (mCRPC), according to a study presented November 30 at RSNA in Chicago. The deep-learning model was trained on PET/CT imaging from 128 patients and identified a high-risk subgroup who may benefit from focused care or alternative therapies, said Andrew Voter, MD, of Johns Hopkins Medicine in Baltimore, MD.“Despite widespread adoption of prostate-specific membrane antigen [PSMA] PET/CT imaging for prostate cancer, prognostication of patient outcomes remains cha...
Source: AuntMinnie.com Headlines - December 12, 2023 Category: Radiology Authors: Will Morton Tags: Subspecialties Molecular Imaging Genitourinary Radiology Source Type: news
Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study - Crump C, Stattin P, Brooks JD, Sundquist J, Edwards AC, Sundquist K, Sieh W.
BACKGROUND: A diagnosis of prostate cancer (PC) may cause psychosocial distress not only in a man but also his intimate partner. However, long-term risks of depression, anxiety, or suicide in partners of men with PC are largely unknown. METHODS: A ... (Source: SafetyLit)
Source: SafetyLit - December 11, 2023 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
Motorist fined £88 for 'littering' when he was caught WEEING in a layby gets penalty overturned... after proving he has a weak bladder (and now the 69-year-old vows to keep a receptacle in his car in case of another emergency!)
Michael Mason, 69, from Winslow, Bucks, was fined £88 for 'littering' after weeing in a layby. But a £30 letter from the GP to prove he has prostate cancer saw the fine binned. (Source: the Mail online | Health)
Source: the Mail online | Health - December 7, 2023 Category: Consumer Health News Source Type: news
TULSA Effective in Controlling Prostate Cancer Long-Term
(MedPage Today) -- WASHINGTON -- Results from a long-term follow-up of the pivotal TACT trial showed that MRI-guided transurethral ultrasound ablation (TULSA) was effective and durable in men with localized prostate cancer.
The median prostate... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - December 5, 2023 Category: Radiology Source Type: news
Why ALL men should take the 30-second check for prostate cancer: Darts stars Gerwyn Price and Gary Anderson urge fans to take action after sponsors Paddy Power announce £1m donation ahead of Ally Pally showpiece
Ahead of the World Darts Championship, the initiative, dubbed 'The Big 180', has also seen tournament sponsor Paddy Power announce it could donate up to £1m to Prostate Cancer UK. (Source: the Mail online | Health)
Source: the Mail online | Health - December 4, 2023 Category: Consumer Health News Source Type: news
